Subscribe
shutterstock_1348256039_pavel_kapysh
Pavel Kapysh / Shutterstock.com
8 August 2019AmericasSarah Morgan

FTC demands Boston Scientific divest business amid $4.2bn deal

The US Federal Trade Commission is requiring medical device maker Boston Scientific to divest business, as part of a settlement resolving antitrust charges related to its acquisition of UK-based healthcare company BTG.

Already registered?

Login to your account

To request a FREE 2-week trial subscription, please signup.
NOTE - this can take up to 48hrs to be approved.

Two Weeks Free Trial

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk


More on this story

Americas
Boston Scientific acquires BTG for $4.2bn
20 November 2018   Medical device manufacturer Boston Scientific today announced that it will acquire UK-based healthcare company BTG for $4.2 billion.
Medtech
US court dismisses infringement, allows trade secret theft claims against Nevro
28 November 2019   A US district court has partially granted medical devices maker Nevro’s motion to dismiss patent infringement claims against the company by a competitor, Boston Scientific.


Editor's picks

Europe
UPC confirms validity of Edwards Lifesciences heart valve tech patent
23 July 2024

Editor's picks

Europe
UPC confirms validity of Edwards Lifesciences heart valve tech patent
23 July 2024

More on this story

Americas
Boston Scientific acquires BTG for $4.2bn
20 November 2018   Medical device manufacturer Boston Scientific today announced that it will acquire UK-based healthcare company BTG for $4.2 billion.
Medtech
US court dismisses infringement, allows trade secret theft claims against Nevro
28 November 2019   A US district court has partially granted medical devices maker Nevro’s motion to dismiss patent infringement claims against the company by a competitor, Boston Scientific.

More on this story

Americas
Boston Scientific acquires BTG for $4.2bn
20 November 2018   Medical device manufacturer Boston Scientific today announced that it will acquire UK-based healthcare company BTG for $4.2 billion.
Medtech
US court dismisses infringement, allows trade secret theft claims against Nevro
28 November 2019   A US district court has partially granted medical devices maker Nevro’s motion to dismiss patent infringement claims against the company by a competitor, Boston Scientific.

More features

Chinese biotech takes out US rival’s nucleic acid patent at PTAB
Lewis Roca promotes tech expert to managing partner
Panitch Schwarze brings in molecular biologist
US targets ‘product hopping’ with biologic litigation curbs
UPC confirms validity of Edwards Lifesciences heart valve tech patent
ITC concludes row over biotech lab equipment between US and German rivals
UKIPO launches ‘revolutionary’ patent filing and AI tool
USPTO clarifies AI's role in patent eligibility